Once Daily Given Alfuzosin in the Treatment of BPH

NCT00637715 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Benign Prostatic Hyperplasia

Interventions

DRUG: Alfuzosin

Sponsor

Sanofi